Pnc Financial Services Group, Inc. Arcellx, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 460 shares of ACLX stock, worth $41,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
460
Previous 751
38.75%
Holding current value
$41,390
Previous $49,000
24.49%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ACLX
# of Institutions
226Shares Held
51.4MCall Options Held
85.4KPut Options Held
113K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.35MShares$572 Million0.32% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$418 Million12.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.91MShares$352 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$316 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.05MShares$274 Million15.63% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.94B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...